Online ordering is open. Ships in 1 to 2 business days. Tracked 2-day shipping, plain box. Every compound third-party tested

For laboratory and research use only. Not for human or veterinary use.

Why peptide costs differ between suppliers

The same peptide can cost very different amounts from two suppliers. This page explains the work behind the gap and the five checks to run before you compare.

13,000
Average process mass intensity, solid-phase synthesisAcross 40 industry processes in one 2024 review
168 to 308
Median for small-molecule drugs in the same review
3
Stages counted: synthesis, purification, isolation

The short answer

Why do two listings for one peptide cost so differently?

The same peptide can come with two very different tags. The gap is rarely luck. It usually comes from how hard the peptide is to make, how much work goes into cleaning it, and how much testing sits behind the vial.

This page walks through each of those costs in plain words. Then it gives you a short list to run on any listing before you compare. Nothing here says one number is right. It shows what a cost can and cannot tell you.

A small number is not a flaw by itself. A small number with no paperwork is a gap you cannot check.

A tray of capped vials
Same peptide name, different work behind the vial

Making it

Why are some peptides harder to make?

Labs build a peptide one amino acid at a time, in a repeating cycle. Each cycle can miss a little. A longer chain means more cycles, so more chances for a miss.

Some sequences are harder than others. A 2026 study looked at how the mix of amino acids drives clumping while a peptide is being built. It found that composition predicted clumping better than the order of the sequence did [1]. Clumping limits how well and how reliably the build runs.

Cost also depends on how many lots miss the mark. A lot that fails its checks has to be made again. The next lot carries that lost time and material.

A hard build can mean more time, more material and more lots that need a redo. That work shows up in what a supplier has to charge.

What makes a build harder
  • A longer chain with more cycles
  • A mix of amino acids that tends to clump
  • Repeat builds when a lot misses its mark
  • More time on the instrument

Materials

How much material goes into one batch?

Solid-phase synthesis uses a large excess of solvents and reagents [2]. A group of 14 pharmaceutical companies pooled data on 40 peptide processes to measure this. Their measure is called process mass intensity. It is the total weight of everything that goes in, compared with the weight of peptide that comes out.

The average for solid-phase peptide synthesis was about 13,000. For small-molecule drugs the median was 168 to 308 [2]. So making a peptide takes far more input per gram than many other products.

A review of greener methods describes the same problem: a lot of waste solvent that someone has to handle [3]. Buying that solvent and handling that waste are real costs for any maker.

13,000Average process mass intensity, solid-phase synthesisAcross 40 industry processes in one 2024 review

The three stages the review counted

StageWhat happens
SynthesisThe chain is built one amino acid at a time
PurificationThe wanted peptide is separated from look-alike by-products
IsolationThe cleaned peptide is turned into a dry powder

Purity

What does a cleaner peptide involve?

After the build, the crude product holds the wanted peptide plus by-products. Some by-products look a lot like the real thing. Purification separates them. The more by-products a lot starts with, the more work this step takes.

Labs then check the result. HPLC, a chromatography test, is one of the tools used to assess peptide content and impurities. Mass spectrometry and NMR are used to check identity [5].

Think of a purity figure as the last line of a long process. It tells you where the lot ended up. It does not tell you how many rounds of cleaning it took to get there.

So a purity figure is the end of a chain of work. If a listing shows a figure with no method and no lab, you cannot tell how it was reached.

A tray of vials in an HPLC instrument
The purity test is a real instrument run, and it costs time

Weight on the label

Why does the label weight not tell the whole story?

Peptides come out of synthesis as salts. The acid used to cut the peptide from its carrier and to clean it, called TFA, stays behind as a counterion [4]. A counterion is a small charged partner that travels with the peptide.

A 2025 study from ETH Zurich removed TFA by freeze-drying the peptides in hydrochloric acid. It measured what was left with three different methods. The authors wrote that counterion content should be measured and stated [4].

This matters when you compare listings. A vial of powder weighs the peptide plus its counterion plus water. Two vials with the same label weight can hold different amounts of actual peptide. The page on net peptide content explains how to read that figure.

What the label weight can include
  • The peptide itself
  • The counterion, such as TFA
  • Leftover water
  • Only a certificate can say how much of each
A label weight alone
  • Counts all the powder
  • Says nothing about the counterion
  • Cannot be compared across suppliers
A certificate that adds net content
  • Names the counterion
  • States how much is peptide
  • Lets you compare cost per milligram of peptide

Paperwork

What does testing add to the cost?

Testing a lot costs money. Peptide quality tests lean on reference standards, which are well-characterized materials used to judge identity, purity and strength [5]. Making and checking those standards is its own project.

A supplier that sends every lot to an outside lab pays that lab each time. A supplier that skips this pays nothing, and the listing shows nothing. That is one honest reason a listing can cost less.

There is also the cost of the paperwork itself. A lot-specific certificate is one document for one lot. A generic PDF is one document for many lots. The first costs more to produce and tells you more. The guide on lot-specific versus generic certificates shows how to spot each.

The way to see the difference is the certificate. Look for a named lab, a lot number that matches your vial, and the methods used. Our guide on how to read a certificate of analysis goes line by line. You can also look up a lot on the certificate page.

A person reading a certificate of analysis
Read the certificate before you compare cost

Your checklist

What should you compare before choosing?

Set the cost aside for a minute. Put the two listings side by side and ask the questions below. If both answer well, the gap is probably real work. If one cannot answer, you have found the gap.

Our supplier checklist covers more checks. The page on third-party testing versus in-house testing explains one of the biggest cost differences.

Five questions for any listing
  • Is the lab named, with a report number?
  • Does the certificate match the lot number on the vial?
  • Are the purity and identity methods stated?
  • Is the counterion or net peptide content shown?
  • Is the amount per vial the peptide or the whole powder?

Questions

Common questions

Is a cheaper peptide worse?

Not always, and not never. The cost alone does not say. The certificate does. Check the lab, the lot number and the methods.

Why does a longer peptide usually cost more?

A longer chain takes more build cycles, and each cycle can miss a little. More cycles also mean more material and more cleaning work.

What is a counterion?

It is a small charged partner that travels with the peptide in the powder. TFA is a common one. It adds weight to the vial.

What is net peptide content?

It is the share of the powder that is the peptide itself. The rest is counterion, water and salts.

Can I compare two listings without a certificate?

Not well. Without a certificate you cannot see the purity method, the lab or the lot. You would be comparing labels only.

Sources

Every study mentioned on this page

Each one links to its record on PubMed, the US National Library of Medicine database.

  1. Amino acid composition drives aggregation during peptide synthesis.Tamás, Alberts, Laino and Hartrampf (Hartrampf is at the University of Zurich). Nature Chemistry, 2026. Built a model from synthesis datasets to predict which amino acid mixes clump during solid-phase peptide synthesis.
  2. Process Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide Synthesis.Kekessie and colleagues, 14 companies in the ACS Green Chemistry Institute Pharmaceutical Roundtable. The Journal of Organic Chemistry, 2024. Pooled process mass intensity data from 40 synthetic peptide processes and split each into synthesis, purification and isolation.
  3. Making Solid-Phase Peptide Synthesis Greener: A Review of the Literature.Varnava and Sarojini, University of Auckland. Chemistry, an Asian Journal, 2019. A review of published work on greener solvents and methods for solid-phase peptide synthesis.
  4. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation.Erckes and colleagues, ETH Zurich. Pharmaceuticals, 2025. Swapped the TFA counterion on synthetic peptides for chloride and measured the leftover TFA by FT-IR, 19F-NMR and HPLC.
  5. Reference Standards to Support Quality of Synthetic Peptide Therapeutics.McCarthy and colleagues, US Pharmacopeial Convention. Pharmaceutical Research, 2023. A review with case studies of how peptide reference standards are made and tested for identity, purity and content.

For the lab

Batch certificates, published

Every product is sold for laboratory research use only. Lab reports with their report numbers are on each product page.

Fast dispatchShips in 1 to 2 business days
Plain packagingNo exterior branding
Tracked shippingTwo business days, flat rate
Third-party testedCertificate on every product page